Cargando…
Tocilizumab: Staphylococcus aureus infection, vancomycin resistant Enterococcus infection, Acinetobacterbaumannii infection and urinary tract infection following off-label use: 4 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843882/ http://dx.doi.org/10.1007/s40278-021-90485-9 |
Ejemplares similares
-
Linezolid to treat urinary tract infections caused by
vancomycin-resistant Enterococcus
por: Pontefract, Benjamin Alan, et al.
Publicado: (2020) -
Incidence of Vancomycin-Resistant Staphylococcus aureus Strains among Patients with Urinary Tract Infections
por: Selim, Samy, et al.
Publicado: (2022) -
Vancomycin Resistance in Enterococcus and Staphylococcus aureus
por: Li, Gen, et al.
Publicado: (2022) -
Tocilizumab: Blood stream infection of methicillin-susceptible Staphylococcus aureus and off label use: case report
Publicado: (2021) -
Genotypic characterization of vancomycin-resistant Enterococcus causing urinary tract infection in northern India
por: Das, Ayan Kumar, et al.
Publicado: (2022)